{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "interpro:IPR003966",
      "entity_text" : "thrombin",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P12804",
      "entity_text" : "prothrombinase",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "XREF_BIBR XREF_BIBR Therefore, we compared rivaroxaban and apixaban in terms of their affinities for free factor Xa and for factor Xa incorporated into the prothrombinase complex and their rates of inhibition of prothrombinase induced thrombin generation and we related these effects to those on the PT, aPTT, and thrombin generation assay.",
  "reading_complete" : "2020-08-03T13:32:04Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:29:22Z",
  "trigger" : "induced",
  "evidence" : [ "prothrombinase-induced thrombin" ],
  "pmc_id" : "6524873",
  "score" : 0
}